Synthesis of metal polyphenol self-assembled nanoparticles based on chlorogenic acid and anti-tumor application of metal polyphenol self-assembled nanoparticles
The metal-phenolic network nanoparticles formed by Cu2+ and chlorogenic acid coordination release Cu2+ and ChA in the acidic environment of tumors, solving the problems of traditional chemotherapy side effects and drug resistance, improving the delivery efficiency and stability of drugs, and significantly enhancing the Anti-tumor effect.
Patent Information
- Application Number
- CN202411072870.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-06
- Publication Date
- 2024-11-22
AI Technical Summary
Traditional chemotherapy has toxic side effects and drug resistance problems during the treatment of tumors, and the half-life of chlorogenic acid is short and quickly removed in the body, affecting its stability and bioavailability in the tumor site.
Metal-phenolic network nanoparticles (ChA-Cu NPs) are formed by coordination between Cu2+ and chlorogenic acid, which releases Cu2+ and ChA in a tumor acidic environment, induces copper death in tumor cells, and realizes the delivery of chemotherapy drugs and synergistically exerts anti-tumor effects.
Responsive release in the acidic environment of tumors is achieved, the drug delivery efficiency and stability is enhanced, the toxic side effects are reduced, and the anti-tumor effect is significantly improved.
Smart Images

Figure CN118986955A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of nanomaterial preparation, and in particular to the synthesis of chlorogenic acid-based metal polyphenol self-assembled nanoparticles and their anti-tumor application. Background Art
[0002] Cancer is a major disease that seriously threatens human life and social development. With the increasing number of patients, it has become the second largest public health problem in the world, second only to cardiovascular disease. At present, chemotherapy is still the most commonly used cancer treatment method in clinical practice. However, traditional chemotherapy will inevitably lead to a series of toxic side effects and drug resistance during the treatment process. In view of the characteristics of the tumor microenvironment (TME), including acidity, high concentrations of glutathione (GSH) and hydrogen peroxide (H2O2), some stimuli-responsive nanocarriers have been used in tumor treatment research. Their advantage is that they can reduce the toxic side effects of drugs and improve the efficiency of drug delivery at the tumor site.
[0003] Chlorogenic acid (ChA) is a desphenolic acid generated by caffeic acid and quinic acid. It is widely distributed in plants and has a wide range of applications in food and medicine. Pharmacological studies have shown that ChA has a variety of biological activities, such as antioxidant, antibacterial, hypoglycemic, anti-atherosclerotic, anti-thrombotic, anti-inflammatory, and anti-cancer effects. Recently, ChA has completed a number of clinical trials, especially a phase I clinical trial for the treatment of recurrent gliomas. The results showed that ChA injection was safe, well tolerated, and had potential anti-tumor effects for patients with recurrent high-grade GBM. Overall, these preclinical and clinical results indicate that ChA may become an attractive candidate for cancer treatment. However, ChA still has limitations in application, such as a short half-life, rapid clearance in the body after injection, and poor patient compliance. Therefore, it is of great significance to enhance its stability and bioavailability by designing a delivery system for chlorogenic acid.
[0004] In recent years, the rise of metal-phenol network structures (MPNs) has provided new possibilities for the efficient delivery of polyphenol-based chemotherapy molecules. The o-diphenolic hydroxyl groups contained in polyphenols can be easily deprotonated under alkaline conditions and can be easily combined with metal ions (such as Fe 3+ , Cu 2+ 、Zn 2+ 、Ce 3+) complexation and rapid self-assembly to form a molecular cross-linked network, which has the advantages of easy synthesis, adjustable structure, excellent biocompatibility, pH responsiveness, etc. It has the characteristics of natural polyphenols and metal ions and is highly designable. In addition, copper death (Cuproptosis) is a recently reported new form of death caused by excess copper. It is different from apoptosis, necroptosis, ferroptosis and pyroptosis. It is a new type of programmed cell death induced by Cu-dependent mitochondrial dysfunction, which shows great promise in overcoming the defects of current tumor chemotherapy. The characteristics of copper death involve abnormal tricarboxylic acid cycle, which leads to the aggregation of sulfylated proteins and the loss of iron-sulfur cluster proteins, thereby inducing proteotoxic stress and ultimately leading to cell death. Therefore, the exogenous introduction of copper is a good candidate to exert copper poisoning. In view of this, the above-mentioned technology is used to construct Cu 2+ Metal-phenolic network nanoparticles (ChA-Cu NPs) coordinated with ChA enable the nanomaterials to release drug polyphenols and metal copper ions in response to the acidic environment of the tumor, thereby achieving responsive release of nanoparticles, inducing copper death of tumor cells and coordinating chemotherapy, which is of great significance. Summary of the invention
[0005] The purpose of the present invention is to overcome the shortcomings of the prior art and provide a synthesis of metal polyphenol self-assembled nanoparticles based on chlorogenic acid and its anti-tumor application. 2+ The metal-polyphenol coordinated nanoparticles (ChA-Cu NPs) are formed by coordination with ChA. The preparation method is simple and efficient. The obtained nanoparticles can release Cu in the acidic environment of tumors. 2+ and ChA, inducing copper death of tumor cells, achieving the delivery of chemotherapeutic drugs, and synergistically exerting anti-tumor effects, so it has good practical application value.
[0006] To achieve the above object, the technical solution of the present invention is as follows:
[0007] The first aspect of the present invention is a method for preparing chlorogenic acid-based metal polyphenol self-assembled nanoparticles, comprising the following steps:
[0008] Step 1: Add sodium hydroxide solution to the chlorogenic acid aqueous solution to adjust the pH of the solution, and the color of the solution changes from colorless to yellow-green;
[0009] Step 2: Add copper chloride solution to the mixed solution obtained in step 1, stir at room temperature, and the color of the solution changes from yellow-green to brown;
[0010] Step 3: Centrifuge and wash the brown product obtained in step 2 to obtain the chlorogenic acid-based metal polyphenol self-assembled nanoparticles.
[0011] Furthermore, in step 1, the pH of the solution is adjusted to 7.0-7.5.
[0012] Furthermore, in step 2, the molar ratio of chlorogenic acid to copper ions is 5:1.
[0013] Furthermore, in step 2, the stirring speed is 400-600 rpm / min, and the stirring time is 6 hours.
[0014] Furthermore, the centrifugal speed in step 3 is 12000 rpm and the time is 20 min.
[0015] The second aspect of the present invention is the chlorogenic acid-based metal polyphenol self-assembled nanoparticles prepared by the preparation method described in the first aspect, which are nanoparticles with a metal-phenolic network structure formed by self-assembly of the phenolic hydroxyl groups of chlorogenic acid and metal copper ions through coordination and chelation.
[0016] Furthermore, the diameter of the nanoparticles is 100-120 nm.
[0017] The third aspect of the present invention is the use of the chlorogenic acid-based metal polyphenol self-assembled nanoparticles described in the second aspect in any one or more of the following:
[0018] (1) preparing drugs that induce copper cell death in tumor cells;
[0019] (2) preparing polyphenol drug delivery systems;
[0020] (3) Preparation of anti-tumor drugs.
[0021] Compared with the prior art, the present invention has the following beneficial effects:
[0022] (1) The present invention utilizes the coordination chelation between the phenolic hydroxyl groups of plant polyphenol chlorogenic acid and transition metal copper ions under alkaline conditions to form a reversible covalently coupled three-dimensional network structure, and finally synthesizes metal-phenolic network nanoparticles with anti-tumor activity. The synthesis method does not require the addition of additional surfactants, etc., and is simple, rapid, and controllable.
[0023] (2) The nanoparticles synthesized in the present invention respond to the acidic microenvironment of the tumor, release chlorogenic acid and copper ions, induce copper cell death in tumor cells, and can undergo a Fenton-like reaction with hydrogen peroxide to produce reactive oxygen species, and have the ability to consume glutathione, thereby synergizing chemotherapy and chemodynamic therapy to achieve anti-tumor effects. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] Figure 1 This is a transmission electron micrograph of the chlorogenic acid-based metal polyphenol self-assembled nanoparticles synthesized in Example 1 of the present invention.
[0025] Figure 2This is the ultraviolet spectroscopic spectrum of the chlorogenic acid-based metal polyphenol self-assembled nanoparticles synthesized in Example 1 of the present invention.
[0026] Figure 3 This is the Fourier transform infrared spectrum of the chlorogenic acid-based metal polyphenol self-assembled nanoparticles synthesized in Example 1 of the present invention.
[0027] Figure 4 This is the XPS spectrum of the chlorogenic acid-based metal polyphenol self-assembled nanoparticles synthesized in Example 1 of the present invention (in the figure, a is the full spectrum of elements in the nanoparticles, b is the X-ray photoelectron spectrum of the Cu element, and c is the X-ray photoelectron spectrum of the O element).
[0028] Figure 5 This is the cumulative release curve of chlorogenic acid under different pH conditions of the chlorogenic acid-based metal polyphenol self-assembled nanoparticles synthesized in Example 1 of the present invention.
[0029] Figure 6 TEM images of chlorogenic acid-based metal polyphenol self-assembled nanoparticles synthesized in Example 1 of the present invention incubated under different acidic conditions for 2 hours.
[0030] Figure 7 This is a study on the generation of reactive oxygen species after the chlorogenic acid-based metal polyphenol self-assembled nanoparticles synthesized in Example 1 of the present invention were co-incubated with hydrogen peroxide.
[0031] Figure 8 This is a study on the consumption of GSH by the chlorogenic acid-based metal polyphenol self-assembled nanoparticles synthesized in Example 1 of the present invention.
[0032] Fig. 9 This is a CCK-8 study on the cytotoxicity of the chlorogenic acid-based metal polyphenol self-assembled nanoparticles synthesized in Example 1 of the present invention.
[0033] Fig.10 This is a cell live-dead staining study of the chlorogenic acid-based metal polyphenol self-assembled nanoparticles synthesized in Example 1 of the present invention.
[0034] Fig.11 This is a protein immunoblot analysis of the chlorogenic acid-based metal polyphenol self-assembled nanoparticles synthesized in Example 1 of the present invention inducing tumor cell death. DETAILED DESCRIPTION
[0035] The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the accompanying drawings in the embodiments of the present invention. The given embodiments are only for illustrating the present invention, not for limiting the scope of the present invention.
[0036] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources.
[0037] Chlorogenic acid was purchased from MacLean Biochemical Technology Co., Ltd. (Shanghai, China), catalog number C805057-1g;
[0038] Cupric chloride dihydrate was purchased from Aladdin Biochemical Technology Co., Ltd. (Shanghai, China);
[0039] Example 1: Synthesis of ChA-Cu NPs
[0040] Prepare a sodium hydroxide solution with a concentration of 1 mol / L for later use;
[0041] Prepare a 36 mg / mL copper chloride solution for later use;
[0042] Take 40 mg of chlorogenic acid, add 4 mL of deionized water, place it in an ultrasonic disperser and ultrasonically disperse it until it is completely dissolved to form a clear and transparent solution, add the pre-prepared sodium hydroxide solution to adjust the pH of the mixed solution to 7.0, and the solution turns yellow-green; slowly add 100 μL of pre-prepared copper chloride solution (the molar ratio of chlorogenic acid and copper ions is 5:1) to the above solution, stir at 500 rpm / min at room temperature for 6 hours, the solution changes from yellow-green to brown, and the brown product is centrifuged at 12000 rpm for 20 minutes and washed with deionized water 3 times to obtain self-assembled nanoparticles based on chlorogenic acid and copper ions, marked as ChA-Cu NPs, which are stored at 4°C for later use.
[0043] Example 2: Characterization of ChA-Cu NPs
[0044] Figure 1 This is a transmission electron micrograph of the chlorogenic acid-based metal polyphenol self-assembled nanoparticles synthesized in Example 1 of the present invention. The ChA-Cu NPs sample was dropped onto a 300-mesh copper grid covered with a carbon film, and after it was naturally dried, it was placed under a transmission electron microscope for observation. As can be seen from the figure, the size of the synthesized nanoparticles is uniformly distributed, the diameter is 100-120 nm, and the morphology is hollow spherical particles.
[0045] Figure 2 The ultraviolet spectra of the chlorogenic acid-based metal polyphenol self-assembled nanoparticles synthesized in Example 1 of the present invention are shown in Figure 1. Chlorogenic acid, copper chloride and ChA-Cu NPs samples were dissolved in aqueous solution, and the absorbance in the wavelength range of 200-800nm was measured on a UV spectrophotometer. As can be seen from the figure, the synthesized nanoparticles show a characteristic absorption peak of ChA at 324nm, indicating that ChA and Cu 2+ coordination.
[0046] Figure 3This is the Fourier transform infrared spectrum of the chlorogenic acid-based metal polyphenol self-assembled nanoparticles synthesized in Example 1 of the present invention. Chlorogenic acid powder and freeze-dried ChA-Cu NPs solid powder were mixed with potassium bromide and pressed into tablets, and the FT-IR spectrum of the samples was collected on a Vertex PerkinElmer 580BIR spectrophotometer (Bruker). As can be seen from the figure, the sharp phenolic hydroxyl peak (3496cm-1) in chlorogenic acid is caused by the formation of coordination bonds between ChA and copper ions. -1 ) disappeared in the synthesized nanoparticles, meanwhile, some other bands present in the FT-IR spectrum of ChA-Cu NPs shifted slightly or disappeared compared with the spectrum of ChA, which means that the metallic copper ions affected the structure of the quinic acid and caffeic acid parts in ChA.
[0047] Figure 4 This is the XPS spectrum of the chlorogenic acid-based metal polyphenol self-assembled nanoparticles synthesized in Example 1 of the present invention (in the figure, a is the full spectrum of elements in the nanoparticles, b is the X-ray photoelectron spectrum of the Cu element, and c is the X-ray photoelectron spectrum of the O element). It can be seen from the figure that the synthesized nanoparticles contain the elements Cu, C and O; according to Figure 4 b. The main ion state of copper in nanoparticles is still Cu 2+ At the same time, a small amount of Cu reduced by ChA appeared + ;according to Figure 4 c, In the XPS spectrum of O element, the characteristic peak of O-Cu can be observed at 531.9 eV, indicating that the Cu in ChA-Cu NPs 2+ Coordination with phenolic hydroxyl groups.
[0048] Example 3: Performance study of ChA-Cu NPs
[0049] Figure 5 Cumulative release curve of chlorogenic acid under different pH conditions for the chlorogenic acid-based metal polyphenol self-assembled nanoparticles synthesized in Example 1 of the present invention. 2 mL of ChA-Cu NPs containing 4 mg was placed in a dialysis bag with a molecular weight cutoff of 3500, and then placed in 40 mL of phosphate buffer of different pH values. At different time points, a certain volume of release medium was taken, and the chlorogenic acid content was calculated by measuring its absorbance at 324 nm, and the phosphate buffer of the same volume and pH was supplemented to ensure that the total volume of the release medium remained unchanged. As shown in the figure, after incubation for 24 hours at pH 5.5 and pH 6.5, the release of chlorogenic acid in the nanoparticles reached 90% and 68%, respectively, while only 30% was released under pH 7.4, indicating that the nanoparticles have pH-dependent ChA release behavior.
[0050] Figure 6TEM images of the chlorogenic acid-based metal polyphenol self-assembled nanoparticles synthesized in Example 1 of the present invention incubated under different acidic conditions for 2 hours. The ChA-Cu NPs were incubated with phosphate buffers of different pH for 2 hours, and the morphological changes of the samples were observed under an electron microscope. As shown in the figure, the morphology of the ChA-Cu NPs did not change significantly in the PBS buffer at pH 7.4, but was destroyed and decomposed in the PBS buffer at pH 6.5, and the structural destruction was more obvious under the condition of pH 5.5, which shows that the synthesized ChA-Cu NPs can respond to acidic conditions to degrade and release ChA and Cu 2+ .
[0051] Figure 7 This is a study on the generation of reactive oxygen species after the chlorogenic acid-based metal polyphenol self-assembled nanoparticles synthesized in Example 1 of the present invention were incubated with hydrogen peroxide. The ability of ChA-Cu NPs to generate ·OH under acidic conditions was evaluated using a methylene blue (MB) indicator. As shown in the figure, after ChA-Cu NPs were incubated with H2O2, the absorbance of MB at 664nm decreased with the increase of ChA-CuNPs concentration, indicating that the nanoparticles can react with hydrogen peroxide to generate ·OH, and the increase in concentration increases.
[0052] Figure 8 This is a study on the consumption of GSH by the chlorogenic acid-based metal polyphenol self-assembled nanoparticles synthesized in Example 1 of the present invention. 5,5'-dithiomethyl (2-nitrobenzoic acid) (DTNB) was used to detect the ability of ChA-Cu NPs to consume glutathione. As shown in the figure, as the concentration of ChA-Cu NPs increased, the absorbance of DTNB at 412nm decreased, that is, the concentration of GSH gradually decreased, indicating that ChA-Cu NPs have the ability to consume GSH.
[0053] Example 4: In vitro antitumor activity of ChA-Cu NPs
[0054] Fig. 9 The cytotoxicity of the chlorogenic acid-based metal polyphenol self-assembled nanoparticles synthesized in Example 1 of the present invention was studied by CCK-8. Different concentrations of ChA-Cu NPs were co-incubated with mouse colon cancer cells (CT26) for 24 hours, and the effect of the nanoparticles on cell viability was analyzed by CellCounting Kit-8 reagent. As can be seen from the figure, under the treatment of a series of nanoparticle concentrations, the cell viability of CT26 tumor cells decreased with the increase of concentration, showing concentration-dependent cytotoxicity. When the concentration reached 400μg·mL -1When treated with ChA-Cu NPs, the viability of CT26 cells decreased to ~24.3%, while free ChA with the same content only decreased the viability of CT26 cells to ~67.7%, indicating that ChA-Cu NPs have a better cell killing effect than free ChA.
[0055] Fig.10 This is a cell live-death staining study of the chlorogenic acid-based metal polyphenol self-assembled nanoparticles synthesized in Example 1 of the present invention. The cells were treated according to different grouping conditions, and calcein (AM, green fluorescence) and propidium iodide (PI, red fluorescence) were used for co-staining to observe live cells and dead cells, and the tumor inhibition effect of the nanoparticles was analyzed. As can be seen from the figure, compared with the control group, slightly more red fluorescence can be observed after the cells are treated with free ChA, however, a large number of dead cells (red fluorescence) can be seen after the cells are treated with ChA-Cu NPs, which further illustrates the excellent in vitro anti-tumor effect of ChA-Cu NPs.
[0056] Fig.11 Protein immunoblotting analysis of chlorogenic acid-based metal polyphenol self-assembled nanoparticles synthesized in Example 1 of the present invention to induce tumor cell death. In order to verify that ChA-Cu NPs induce copper death in tumor cells, cells were treated with different grouping conditions, total intracellular protein was extracted after 24 hours of incubation, and the expression of different proteins was detected by Western blotting. As shown in the figure, compared with the control group and free ChA, the synthesized nanoparticles can significantly reduce the expression of Fe-S cluster protein ferredoxin (FDX1), indicating that ChA-Cu NPs can destroy the stability of Fe-S cluster protein ferredoxin, and ultimately lead to copper death of tumor cells; in addition, the expression level of the key apoptosis protein caspase-3 was also studied, and the results showed that ChA-Cu NPs can cause a significant decrease in the expression of caspase-3 in tumor cells, indicating that the synthesized ChA-Cu NPs can induce cell apoptosis.
[0057] The above is only a detailed description of the preferred implementation mode of the present invention, but the present invention is not limited to the above embodiments. Within the knowledge scope of ordinary technicians in this field, several improvements and supplements can be made without departing from the purpose of the present invention. These improvements and supplements should be included in the protection scope of the present invention.
Claims
1. A method for synthesizing metal polyphenol self-assembled nanoparticles based on chlorogenic acid, characterized in that: The following steps are involved: Step 1: Add sodium hydroxide solution to the chlorogenic acid aqueous solution to adjust the pH of the solution, and the color of the solution changes from colorless to yellow-green; Step 2: Add copper chloride solution to the mixed solution obtained in step 1, stir at room temperature, and the color of the solution changes from yellow-green to brown; Step 3: Centrifuge and wash the brown product obtained in step 2 to obtain the chlorogenic acid-based metal polyphenol self-assembled nanoparticles.
2. The method for synthesizing chlorogenic acid-based metal polyphenol self-assembled nanoparticles according to claim 1, characterized in that: In the step 1, the pH of the solution is adjusted to 7.0-7.
5.
3. The method for synthesizing chlorogenic acid-based metal polyphenol self-assembled nanoparticles according to claim 1, characterized in that: In step 2, the molar ratio of chlorogenic acid to copper ions is 5:
1.
4. The method for synthesizing chlorogenic acid-based metal polyphenol self-assembled nanoparticles according to claim 1, characterized in that: The stirring speed in step 2 is 400-600 rpm / min, and the stirring time is 6 hours.
5. The method for synthesizing chlorogenic acid-based metal polyphenol self-assembled nanoparticles according to claim 1, characterized in that: The centrifugal speed in step 3 is 12000 rpm and the time is 20 min.
6. The chlorogenic acid-based metal polyphenol self-assembled nanoparticles obtained by the synthesis method according to any one of claims 1 to 5, characterized in that: The nanoparticles are nanoparticles with a metal-phenolic network structure that are self-assembled by the phenolic hydroxyl groups of chlorogenic acid and metal copper ions through coordination and chelation.
7. The chlorogenic acid-based metal polyphenol self-assembled nanoparticles according to claim 6, characterized in that: The diameter of the nanoparticles is 100-120 nm.
8. Use of the chlorogenic acid-based metal polyphenol self-assembled nanoparticles according to claim 6 or 7 in any one or more of the following: (1) Synthesize drugs that induce copper death in tumor cells; (2) Synthetic polyphenol drug delivery systems; (3) Synthesize anti-tumor drugs.
Citation Information
Patent Citations
Metal polyphenol nano-composite as well as preparation method and application thereof
CN111939174A
Chlorogenic acid-baicalin co-loaded nanoparticle nasal cavity in-situ gel as well as preparation method and application thereof
CN114522137A
Living cell drug delivery system and preparation method and application thereof
CN117018222A
Compositions and methods of controlling and administering redox specific forms of drugs, foods and dietary supplements
US20100021989A1
Thermoformable dual network hydrogel compositions
US20180311358A1
Cited By
New application of combined use of chlorogenic acid and copper ions, ROS (reactive oxygen species) response type nano assembly as well as preparation method and application of ROS response type nano assembly
CN120361046A
Metal-nucleic acid coordination nano system as well as preparation method and application thereof
CN122272639A
